Executive readout · one minute
Call research workspace
Read the call alongside every captured source. slides, 8-K earnings release, 10-Q stay in one workspace.
TBPH
$17.06
+0.00%
TBPH
· Theravance Biopharma, Inc.
Market Cap
$886.77M
Shares
51.92M
All earnings calls
Earnings call · FY2026 Q1
Theravance Biopharma, Inc. (TBPH) Q1 2026 Earnings Call
Forward guidance
1 guided metrics
Management's latest ranges and targets are included below.
Research coverage
3 live sources
Open each available source without leaving this research workspace.
Revenue
$17.70M
+15% YoY
Diluted EPS
-$0.10
Net income
-$4.93M
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed May 7, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
One-time cash severance costs
next two quarters
|
$5M – $7M | — |
Company presentation
Slides
9 pages · use arrow keys or swipe to navigate
SEC filing · Item 2.02
8-K earnings release
Filed May 7, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed May 7, 2026 · complete as-filed document